EP Patent

EP2488165B1 — Nanoparticle of the core-shell type suitable for delivering therapeutic oligonucleotides to target tissues and the use thereof for the preparation of a medicament for treating duchenne muscular dystrophy

Assigned to Universita degli Studi di Ferrara · Expires 2014-07-23 · 12y expired

What this patent protects

Patent listed against Exondys 51.

Drugs covered by this patent

Patent Metadata

Patent number
EP2488165B1
Jurisdiction
EP
Classification
—
Expires
2014-07-23
Drug substance claim
No
Drug product claim
No
Assignee
Universita degli Studi di Ferrara
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.